Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
Open accessThe DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Both glucose and triglyceride production are increased in type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). For decades, the leading hypothesis to explain these paradoxical observations has been selective hepatic insulin resistance wherein insulin drives de novo lipogenesis (DNL) while failing to suppress glucose production. Here, we aimed to test this hypothesis in humans. RESEARCH DESIGN AND METHODS: We recruited obese subjects who met criteria for bariatric surgery with (n = 16) or without (n = 15) NAFLD and assessed 1) insulin-mediated regulation of hepatic and peripheral glucose metabolism using hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose, 2) fasting and carbohydrate-driven hepatic DNL using deuterated water (2H2O), and 3) hepatocellular insulin signaling in liver biopsy samples collected during bariatric surgery. RESULTS: Compared with subjects without NAFLD, those with NAFLD demonstrated impaired insulin-mediated suppression of glucose production and attenuated—not increased—glucose-stimulated/high-insulin lipogenesis. Fructose-stimulated/low-insulin lipogenesis was intact. Hepatocellular insulin signaling, assessed for the first time in humans, exhibited a proximal block in insulin-resistant subjects: Signaling was attenuated from the level of the insulin receptor through both glucose and lipogenesis pathways. The carbohydrate-regulated lipogenic transcription factor ChREBP was increased in subjects with NAFLD. CONCLUSIONS: Acute increases in lipogenesis in humans with NAFLD are not explained by altered molecular regulation of lipogenesis through a paradoxical increase in lipogenic insulin action; rather, increases in lipogenic substrate availability may be the key.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, Ter Horst et al. [70] demonstrated that glucose-stimulated, insulin-mediated DNL was not elevated in insulin-resistant steatotic livers, calling into question the notion that increased hepatic lipogenesis in human MASLD is primarily driven by pathway-selective insulin action.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [70]
In the citing paper
“In contrast, glucose-stimulated hepatic DNL was significantly higher in control subjects with greater insulin sensitivity.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [70]
In the citing paper
“Moreover, fructose—a substrate that enters hepatocytes independently of insulin—robustly induced gene expression of the active ChREBPβ isoform and stimulated hepatic lipogenesis in obese individuals regardless of MASLD status [70,86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [70]
In the citing paper
“Thus, in individuals with IR, an increase in hepatic insulin action may not be necessary to explain the upregulated DNL; rather, it is likely driven by an excess supply of lipogenic substrates—including carbohydrates such as fructose as well as amino acids, lactate, and citrate—that fuel hepatic DNL [70,86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [70]
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [70]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationCalculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
Self-citationBrunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders—European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO), Fried, M., Yumuk, V., Oppert, J. M., Scopinaro, N., Torres, A., Weiner, R., Yashkov, Y., & Frühbeck, G. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1079-8 · Cited by 753
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Sanyal, A. J., Brunt, E. M., Kleiner, D. E., Kowdley, K. V., Chalasani, N., Lavine, J. E., Ratziu, V., & McCullough, A. (2011) · Hepatology · doi:10.1002/hep.24376 · Cited by 750
Perry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719
Self-citationA novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
Herman, M. A., Peroni, O. D., Villoria, J., Schön, M. R., Abumrad, N. A., Blüher, M., Klein, S., & Kahn, B. B. (2012) · Nature · doi:10.1038/nature10986 · Cited by 596
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585
Self-citationFinegood, D. T., Bergman, R. N., & Vranic, M. (1987) · Diabetes · doi:10.2337/diab.36.8.914 · Cited by 546
Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package
Stefan, D., Cesare, F. D., Andrasescu, A., Popa, E., Lazariev, A., Vescovo, E., Strbak, O., Williams, S., Starcuk, Z., Cabanas, M., et al. (2009) · Measurement Science and Technology · doi:10.1088/0957-0233/20/10/104035 · Cited by 514
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497
Self-citationSummers, S. A., Garza, L. A., Zhou, H., & Birnbaum, M. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5457 · Cited by 475
Radiologic evaluation of nonalcoholic fatty liver disease
Lee, S. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7392 · Cited by 426
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Ter Horst, K., & Serlie, M. (2017) · Nutrients · doi:10.3390/nu9090981 · Cited by 365
Self-citationDulai, P. S., Sirlin, C. B., & Loomba, R. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.005 · Cited by 356
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
Fried, M., Yumuk, V., Oppert, J.-M., Scopinaro, N., Torres, A. J., Weiner, R., Yashkov, Y., & Frühbeck, G. (2013) · Obesity Facts · doi:10.1159/000355480 · Cited by 316
Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
Petersen, M. C., Madiraju, A. K., Gassaway, B. M., Marcel, M., Nasiri, A. R., Butrico, G., Marcucci, M. J., Zhang, D., Abulizi, A., Zhang, X.-M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86013 · Cited by 240
Self-citationInsulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235
Self-citationEffect of liver fat on insulin clearance
Kotronen, A., Vehkavaara, S., Seppälä-Lindroos, A., Bergholm, R., & Yki-Järvinen, H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2007 · Cited by 202
Rabøl, R., Petersen, K. F., Dufour, S., Flannery, C., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110105108 · Cited by 196
Self-citationmTORC1 signaling in hepatic lipid metabolism
Han, J., & Wang, Y. (2018) · Protein & Cell · doi:10.1007/s13238-017-0409-3 · Cited by 170
Flannery, C., Dufour, S., Rabøl, R., Shulman, G. I., & Petersen, K. F. (2012) · Diabetes · doi:10.2337/db12-0206 · Cited by 168
Self-citationter Horst, K. W., Gilijamse, P. W., Versteeg, R. I., Ackermans, M. T., Nederveen, A. J., la Fleur, S. E., Romijn, J. A., Nieuwdorp, M., Zhang, D., Samuel, V. T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.035 · Cited by 162
Self-citationKubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12977 · Cited by 143
Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans
Diraison, F., Yankah, V., Letexier, D., Dusserre, E., Jones, P., & Beylot, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200461-jlr200 · Cited by 140
In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis
Lee, W. N., Bassilian, S., Ajie, H. O., Schoeller, D. A., Edmond, J., Bergner, E. A., & Byerley, L. O. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.5.e699 · Cited by 130
Diraison, F., Pachiaudi, C., & Beylot, M. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90152-3 · Cited by 95
Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux
Otero, Y. F., Stafford, J. M., & McGuinness, O. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.576355 · Cited by 94
Ackermans, M. T., Pereira Arias, A. M., Bisschop, P. H., Endert, E., Sauerwein, H. P., & Romijn, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7383 · Cited by 94
Self-citationMethods for quantifying adipose tissue insulin resistance in overweight/obese humans
ter Horst, K. W., van Galen, K. A., Gilijamse, P. W., Hartstra, A. V., de Groot, P. F., van der Valk, F. M., Ackermans, M. T., Nieuwdorp, M., Romijn, J. A., & Serlie, M. J. M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.110 · Cited by 88
Self-citationAckermans, M. T. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2220 · Cited by 85
Self-citationRuijter, J. M., Lorenz, P., Tuomi, J. M., Hecker, M., & van den Hoff, M. J. B. (2014) · Microchimica Acta · doi:10.1007/s00604-013-1155-8 · Cited by 83
Fatty acid synthesis by the liver perfused with deuterated and tritiated water
Wadke, M., Brunengraber, H., Lowenstein, J. M., Dolhun, J. J., & Arsenault, G. P. (1973) · Biochemistry · doi:10.1021/bi00738a011 · Cited by 72
Insulin resistance in obesity can be reliably identified from fasting plasma insulin
ter Horst, K. W., Gilijamse, P. W., Koopman, K. E., de Weijer, B. A., Brands, M., Kootte, R. S., Romijn, J. A., Ackermans, M. T., Nieuwdorp, M., Soeters, M. R., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.125 · Cited by 69
Self-citationStable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism1,2
Murphy, E. J. (2006) · Journal of Animal Science · doi:10.2527/2006.8413_supple94x · Cited by 67
CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistance
Summers, S. A., & Goodpaster, B. H. (2016) · The Journal of Physiology · doi:10.1113/jp271676 · Cited by 48
ter Horst, K. W., Gilijamse, P. W., Ackermans, M. T., Soeters, M. R., Nieuwdorp, M., Romijn, J. A., & Serlie, M. J. M. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.010 · Cited by 40
Self-citationJones, P. J. H. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-74-6-755 · Cited by 36
van der Valk, F., Hassing, C., Visser, M., Thakkar, P., Mohanan, A., Pathak, K., Dutt, C., Chauthaiwale, V., Ackermans, M., Nederveen, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086890 · Cited by 31
Self-citationter Horst, K. W., Gilijamse, P. W., Demirkıran, A., van Wagensveld, B. A., Ackermans, M. T., Verheij, J., Romijn, J. A., Nieuwdorp, M., Maratos–Flier, E., Herman, M. A., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.014 · Cited by 31
Self-citationLactate increases hepatic secretion of VLDL-triglycerides in humans
Sondermeijer, B. M., Battjes, S., van Dijk, T. H., Ackermans, M. T., Serlie, M. J. M., Nieuwdorp, M., Groen, A. K., Dallinga‐Thie, G. M., & Stroes, E. S. G. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.040 · Cited by 9
Self-citation
Research works printed but not linked: 1
- Jones, 1996, Tracing lipogenesis in humans using deuterated water, Can J Physiol Pharmacol, 74, 755, 10.1139/y96-070 · doi:10.1139/y96-070 · Paper page
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Self-citationWhy does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939
A Global View of the Interplay between Non-Alcoholic Fatty Liver Disease and Diabetes
Stefan, N., & Cusi, K. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00003-1 · Cited by 593
Stefan, N., Yki-Järvinen, H., & Neuschwander-Tetri, B. A. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00318-8 · Cited by 392
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Metadata
- Authors
- ter Horst, K. W., Vatner, D. F., Zhang, D., Cline, G. W., Ackermans, M. T., Nederveen, A. J., Verheij, J., Demirkiran, A., van Wagensveld, B. A., Dallinga-Thie, G. M., Nieuwdorp, M., Romijn, J. A., Shulman, G. I., & Serlie, M. J.
- Affiliations
- Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, the Netherlands
- Yale University (US)
- Department of Clinical Chemistry, Laboratory of Endocrinology, Amsterdam University Medical Center, Amsterdam, the Netherlands
- Amsterdam UMC Location University of Amsterdam (NL)
- Department of Surgery, Red Cross Hospital, Beverwijk, the Netherlands
- Department of Surgery, OLVG West, Amsterdam, the Netherlands
- Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands
- Amsterdam University Medical Centers (NL)
- Corresponding author
- Serlie, Mireille J.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-08
- Volume
- 44
- Issue
- 2
- Pages
- 489-498
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7818337
- OpenAlex
- W3110973280
- Cited by
- 88
- References
- 54
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 20 · 2023: 17 · 2022: 9 · 2021: 16
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
- Funders
- European Commission (FP7-EU 305707)
- National Institutes of Health (R01-DK-124272, K23-DK-10287)
- ZonMw (VIDI 016.146.327)
- Hartstichting (CVON IN-CONTROL, R01-DK-113984, R01-DK-119968, P30-DK-45735)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, hepatic insulin resistance, de novo lipogenesis, hepatic glucose production, insulin signaling, insulin receptor, ChREBP, fructose, hyperinsulinemic-euglycemic clamp, bariatric surgery, obesity
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Liver, Lipogenesis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.